Delivery Order SPE2DB20D2104-SPE2DB24FS79V
Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,089.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,148,061 units of Mirtazapine 30 mg tablets, a medication used for the treatment of mental health conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,537,161 units of the pharmaceutical product Mirtazapine 7.5 mg tablet, with a ceiling value of $4,515.79 and a completion date of April 11, 2023. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mirtazapine 7.5 mg tablets in 30-count packages, with a ceiling value of $5,187.46 and a completion date of July 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.34 firm fixed-price contract is for the delivery of 1,000 units of the medication mirtazapine 15 mg tablets. The award has an ultimate completion date of August 15, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,891,757 units of mirtazapine 7.5 mg tablets. The award has a ceiling value of $6,426.97 and a period of performance through September 23, 2024. This contract is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
- The Defense Logistics Agency awarded a delivery order valued at $1,021.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mirtazapine 7.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, valued at $5,732.50 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,485.94 delivery order covers the supply of 4,554,646,199 units of the antidepressant medication mirtazapine 15 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.33 firm fixed-price delivery order is for the supply of Mirtazapine 7.5 mg tablets, a medication used to treat mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mirtazapine 7.5 mg tablets. The contract has a firm fixed price of $1,056.18 and a completion date of July 29, 2022. The award is not designated as a set-aside and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS79VDelivery Order
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,360.95. The order is for 4,563,802,790 tablets of the antidepressant medication mirtazapine 30 mg. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order does not have a set-aside designation, indicating it was competitively awarded.
Generated 2/27/25, 12:06 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/28/24 |